← Back to Search

Crohn's disease for Crohn's Disease (CIMPA Trial)

N/A
Recruiting
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up december 2019 - january 2025
Awards & highlights

Summary

This study postulates that altered microbiota associated with areas of mucosal inflammation in CD, can be characterized by an increased proteolytic profile. This is clinically important as it may be possible to modulate the proteolytic activity of the CD-associated bacteria by using other bacteria that produce protease inhibitors, such as serpins.

Eligible Conditions
  • Crohn's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~december 2019 - january 2025
This trial's timeline: 3 weeks for screening, Varies for treatment, and december 2019 - january 2025 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Altered microbiota associated with areas of mucosal inflammation in CD, is characterized by an increased proteolytic profile

Trial Design

1Treatment groups
Experimental Treatment
Group I: Crohn's diseaseExperimental Treatment1 Intervention
Patients previously diagnosed with Crohn's disease who have a clinical indication for undergoing a standard white light colonoscopy, as determined by their gastroenterologist, will be invited to participate. Patients undergoing colonoscopy for other indications (for example, for the investigation of possible malignancy, polyps, gastrointestinal bleeding or diarrhea, without colonic inflammation), will not be included in this study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Colonoscopy
2012
Completed Phase 3
~115560

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
906 Previous Clinical Trials
2,613,211 Total Patients Enrolled
~1 spots leftby Jan 2025